These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3520867)

  • 1. [Comparative study of the action of hypolipemic and antioxidant drugs in ischemic heart disease].
    Kalmykova VI; Nikitina EK; Bezzubov AA
    Sov Med; 1986; (3):81-4. PubMed ID: 3520867
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antioxidant therapy in various clinico-biochemical variants of ischemic heart disease].
    Dudchenko MA; Rasin MS; Kazakov IuM; Potiazhenko MM; Chichkalo OV
    Vrach Delo; 1986 Apr; (4):31-3. PubMed ID: 3521087
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of hypolipemic effect of atheroid in ischemic heart disease associated with various types of hyperlipoproteinemia].
    Zakharov VN
    Sov Med; 1978 Jan; (1):147-8. PubMed ID: 76342
    [No Abstract]   [Full Text] [Related]  

  • 4. [The diagnosis and treatment of coronary heart disease in chronic renal failure].
    Belialov FI
    Klin Med (Mosk); 2004; 82(10):8-12. PubMed ID: 15584591
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid altering or antioxidant vitamins for patients with coronary disease and very low HDL cholesterol? The HDL-Atherosclerosis Treatment Study Design.
    Brown BG; Zhao XQ; Chait A; Frohlich J; Cheung M; Heise N; Dowdy A; DeAngelis D; Fisher LD; Albers J
    Can J Cardiol; 1998 Apr; 14 Suppl A():6A-13A. PubMed ID: 9594927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A double blind study of the new hypolipidemic agent pirozadil (722-D) using patients with ischemic heart disease (author's transl)].
    Cadierno Carpintero M; Emeterio Reig E; Soler Masana JM
    Med Clin (Barc); 1982 May; 78(9):386-9. PubMed ID: 7047927
    [No Abstract]   [Full Text] [Related]  

  • 7. [Necessity of hypolipemic treatment in patients with coronary disease].
    Fernández-Miranda C; Aranda IL
    Med Clin (Barc); 1999 Mar; 112(11):438. PubMed ID: 10231779
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of coronary atherosclerosis by the use of combination therapy with antioxidant coenzyme Q10 and statins.
    Chapidze G; Kapanadze S; Dolidze N; Bachutashvili Z; Latsabidze N
    Georgian Med News; 2005 Jan; (118):20-5. PubMed ID: 15821319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental and clinical assessment of antioxidant efficacy of multicomponent antioxidant medication].
    Lankin VZ; Tikhaze AK; Konovalova GG; Lisina MO; Nezhdanova IB; Gamboeva SB; Kukharchuk VV; Belenkov IuN
    Ter Arkh; 2004; 76(8):10-5. PubMed ID: 15471387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of hypolipidemic agents on the content of sterol-fibrinogen complexes of the blood in patients with ischemic heart disease].
    Palamarchuk VI; Fedorishko SS
    Vrach Delo; 1989 Jan; (1):39-41. PubMed ID: 2718441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipids and their role in coronary heart disease: what they do and how to manage them.
    Pradka LR
    Nurs Clin North Am; 2000 Dec; 35(4):981-91. PubMed ID: 11072283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trials and tribulations.
    Packard CJ
    Int J Clin Pract Suppl; 2002 Oct; (132):3-10. PubMed ID: 12425357
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of atherosclerosis with hypolipidemic and antiuricemic agents].
    Plastinina RA; Oleĭnik NA; Valeeva RM; Pavlova TN
    Sov Med; 1984; (1):83-7. PubMed ID: 6701660
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of the antioxidant dibunol on the composition and lipid peroxidation intensity of the blood of ischemic heart disease patients].
    Sal'nikov MI; Barsel' VA; Arkhipova GV
    Dokl Akad Nauk SSSR; 1984; 278(3):747-51. PubMed ID: 6499651
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy and clinical trials.
    Curr Opin Lipidol; 1995 Dec; 6(6):B77-82. PubMed ID: 8750254
    [No Abstract]   [Full Text] [Related]  

  • 17. Halofenate: an effective hypolipemia- and hypouricemia-inducing drug.
    Aronow WS; Vangrow JS; Nelson WH; Pagano J; Papageorge's NP; Khursheed M; Harding PR; Khemka M
    Curr Ther Res Clin Exp; 1973 Dec; 15(12):902-6. PubMed ID: 4203573
    [No Abstract]   [Full Text] [Related]  

  • 18. Niaspan: new hope for heart patients.
    Creavin T
    Drug Discov Today; 2005 Jan; 10(1):4-5. PubMed ID: 15676289
    [No Abstract]   [Full Text] [Related]  

  • 19. Antioxidant supplements and simvastatin-niacin therapy.
    Netke S; Ivanov V; Roomi W; Niedzwiecki A; Rath M
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2099-100. PubMed ID: 11742891
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of the antioxidant, ionol, on blood coagulation in ischemic heart disease].
    Shkliar AS
    Vrach Delo; 1980 Sep; (9):52-4. PubMed ID: 7423951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.